| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |